• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ocuphire Pharma Inc (NQ: OCUP )

    1.250 +0.030 (+2.46%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 10,973
    Open 1.250
    Bid (Size) 1.230 (16)
    Ask (Size) 1.270 (75)
    Prev. Close 1.220
    Today's Range 1.250 - 1.250
    52wk Range 1.160 - 4.500
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024
    OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains
    These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist. 
    Via Talk Markets

    Performance

    YTD
    -59.28%
    -59.28%
    1 Month
    -39.61%
    -39.61%
    3 Month
    -25.15%
    -25.15%
    6 Month
    -52.65%
    -52.65%
    1 Year
    -68.67%
    -68.67%

    More News

    Read More
    Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
    Via Benzinga
    OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Recap: Ocuphire Pharma Q3 Earnings
    Via Benzinga
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
    Via InvestorPlace
    3 Value Stocks to Buy on the Dip: February 2024
    Via InvestorPlace
    Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024
    Via InvestorPlace
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Surprise! These 3 Penny Stocks Pack Powerful Financials.
    Via InvestorPlace
    The 7 Best Stocks Under $10 to Buy in May
    Via InvestorPlace
    7 Small-Cap Biotech Stocks with Massive Potential
    Via InvestorPlace
    Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case
    Via Benzinga
    Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    US Stocks Mostly Lower; Nasdaq Down 50 Points
    Via Benzinga
    Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    7 Thrilling Biotech Stocks for Aggressive Investors to Buy
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.